Sleep Apnea Completed Phase 1 / 2 Trials for Liraglutide (DB06655)

Also known as: Sleep apnoeas / Sleep Apnoea / Sleep Apnea Syndrome / Apnea, Sleep / Sleep Apnea Syndromes / Sleep apnoea syndromes / Sleep apnoea syndrome / Apnea syndrome / Apnoea syndrome

IndicationStatusPhase
DBCOND0030087 (Sleep Apnea)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01832532A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 WeeksTreatment